Vitamin d receptor bsmi polymorphism and ovarian cancer risk : A meta-analysis

International Journal of Gynecological Cancer

Volumn 23, Issue 7, 2013, Pages 1178-1183

  Qin, Xue ^a   Lu, Yu ^a   Qin, Aiping ^a   Chen, Zhiping ^b   Peng, Qiliu ^a   Deng, Yan ^a   Xie, Li ^a   Wang, Jian ^a   Li, Ruolin ^a   Zeng, Jie ^c   Li, Shan ^a   Zhao, Jinmin ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

^c LIUZHOU PEOPLE S HOSPITAL   (China)

Author keywords

Meta analysis; Ovarian cancer; Polymorphism; Vitamin d receptor (VDR)

Indexed keywords

VITAMIN D RECEPTOR;

CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; COMPARATIVE STUDY; DISEASE COURSE; DOMINANT INHERITANCE; HUMAN; META ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTORS, CALCITRIOL; RISK FACTORS;

EID: 84884527910     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31829db839     Document Type: Review

References (20)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet. 1995;57:1457-1462.
3. Lefkowitz ES, Garland CF. Sunlight, vitamin D, and ovarian cancer mortality rates in US women. Int J Epidemiol. 1994;23:1133-1136.
4. Ahonen MH, Zhuang YH, Aine R, et al. Androgen receptor and vitamin D receptor in human ovarian cancer: growth stimulation and inhibition by ligands. Int J Cancer. 2000;86:40-46.
5. Zhang X, Jiang F, Li P, et al. Growth suppression of ovarian cancer xenografts in nude mice by vitamin D analogue EB1089. Clin Cancer Res. 2005;11:323-328.
6. Baker AR, McDonnell DP, Hughes M, et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci U S A. 1988;85:3294-3298.
7. Anderson MG, Nakane M, Ruan X, et al. Expression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother Pharmacol. 2006;57:234-240.
8. Lurie G, Wilkens LR, Thompson PJ, et al. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk. Cancer Epidemiol Biomarkers Prev. 2007;16:2566-2571.
9. Thomas MG, Tebbutt S, Williamson RC. Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line. Gut. 1992;33:1660-1663.
10. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst. 1998;90:1774-1786.
11. Clendenen TV, Arslan AA, Koenig KL, et al. Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer. Cancer Lett. 2008;260:209-215.
12. Tworoger SS, Gates MA, Lee IM, et al. Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies. Cancer Res. 2009;69:1885-1891.
13. Grant DJ, Hoyo C, Akushevich L, et al. Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women. Gynecol Oncol. 2013;129:173-179.
14. Mostowska A, Sajdak S, Pawlik P, et al. Vitamin D receptor gene BsmI and FokI polymorphisms in relation to ovarian cancer risk in the Polish population. Genet Test Mol Biomarkers. 2013;17:183-187.
15. Lurie G, Wilkens LR, Thompson PJ, et al. Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium. Int J Cancer. 2011;128:936-943.
16. Uitterlinden AG, Fang Y, Van Meurs JB, et al. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338:143-156.
17. Jurutka PW, Whitfield GK, Hsieh JC, et al. Molecular nature of the vitamin D receptor and its role in regulation of gene expression. Rev Endocr Metab Disord. 2001;2:203-216.
18. Luo XY, Yang MH, Wu FX, et al. Vitamin D receptor gene BsmI polymorphism B allele, but not BB genotype, is associated with systemic lupus erythematosus in a Han Chinese population. Lupus. 2012;21:53-59.
19. Parkin DM. International variation. Oncogene. 2004;23: 6329-6340.
20. Kostner K, Denzer N, Muller CS, et al. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: A review of the literature. Anticancer Res. 2009;29:3511-3536.